[{"NetIncomeLoss_1_Q3_USD":-67526000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":51875315.0,"CommitmentsAndContingencies_0_Q3_USD":null,"AccruedLiabilitiesCurrent_0_Q3_USD":39016000.0,"RepaymentsOfDebtAndCapitalLeaseObligations_3_Q3_USD":0.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":null,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-27939000.0,"Depreciation_3_Q3_USD":722000.0,"AssetsCurrent_0_Q3_USD":805506000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":8212019.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":2042000.0,"CommonStockSharesIssued_0_Q3_shares":51698775.0,"Assets_0_Q3_USD":958206000.0,"ShareBasedCompensation_3_Q3_USD":33389000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":68450000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":3228000.0,"CommonStockSharesAuthorized_0_Q3_shares":490000000.0,"OperatingIncomeLoss_3_Q3_USD":-174002000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":51722611.0,"GeneralAndAdministrativeExpense_1_Q3_USD":11533000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":32259000.0,"MarketableSecuritiesCurrent_0_Q3_USD":null,"ResearchAndDevelopmentExpense_1_Q3_USD":56002000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":-53000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":0.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-76000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-25000.0,"CommonStockValue_0_Q3_USD":5000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":6025000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":24500000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q3_USD":799200000.0,"OperatingIncomeLoss_1_Q3_USD":-67535000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_3_Q3_USD":0.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-173878000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-67526000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":3255000.0,"OtherAssetsNoncurrent_0_Q3_USD":54987000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":799247000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":77338000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":1191367000.0,"Liabilities_0_Q3_USD":231886000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_1_Q3_USD":0.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_3_Q3_USD":0.0,"InvestmentIncomeInterest_3_Q3_USD":270000.0,"InvestmentIncomeInterest_1_Q3_USD":40000.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":0.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":-53000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":0.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":0.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":12377000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-123235000.0,"LiabilitiesCurrent_0_Q3_USD":54396000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_Q3_USD":-145149000.0,"AccountsPayableCurrent_0_Q3_USD":13761000.0,"RestrictedCashNoncurrent_0_Q3_USD":6324000.0,"InterestExpense_3_Q3_USD":17000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_3_Q3_USD":305000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":6259000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":5753000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":797000.0,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":936000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":805571000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":22939000.0,"NetIncomeLoss_3_Q3_USD":-173825000.0,"InterestExpense_1_Q3_USD":6000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":141743000.0,"NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_3_Q3_USD":10730000.0,"MarketableSecurities_0_Q3_USD":0.0,"PreferredStockValue_0_Q3_USD":null,"LiabilitiesAndStockholdersEquity_0_Q3_USD":958206000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":4790000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":33389000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":12377000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q3_USD":122400000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1619000.0,"OperatingExpenses_3_Q3_USD":174002000.0,"CommonStockSharesOutstanding_0_Q3_shares":51698775.0,"OperatingExpenses_1_Q3_USD":67535000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":583000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-3.36,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-1.3,"OtherLiabilitiesNoncurrent_0_Q3_USD":223000.0,"StockholdersEquity_0_Q3_USD":726320000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q3_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":8598000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-25000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-465052000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":10547000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":223000.0,"Ticker":"KOD","CIK":"1468748","name":"KODIAK SCIENCES INC.","OfficialName":"Kodiak Sciences Inc Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"350038530.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211109"}]